Israel Anita, Arzola Jorge, De Jesús Sara, Varela Maider
Laboratory of Neuropeptides, School of Pharmacy, Central University of Venezuela, Caracas, Venezuela.
J Renin Angiotensin Aldosterone Syst. 2009 Mar;10(1):9-14. doi: 10.1177/1470320309102946.
Central administration of angiotensin II (Ang II) is known to reduce urinary volume and to increase sodium and potassium excretion. Recently, a novel signalling mechanism for Ang II in the periphery has been shown to involve reduced nicotinamide adenine dinucleotide phosphate [NAD(P)H] oxidase-derived reactive oxygen species (ROS).Although ROS are now known to be involved in numerous Ang II-regulated processes in peripheral tissues, and are increasingly implicated in CNS neurodegenerative diseases, the role of ROS in central regulation of Ang II-induced hydromineral metabolism remains unexplored.The hypothesis that ROS are involved in central Ang II signalling and in Ang II-dependent antidiuresis, natriuresis and kaliuresis was tested by the use of selective antagonists of the NAD(P)H oxidase cascade.
In intracerebroventricular (ICV)-cannulated rats,Ang II was injected ICV and urinary sodium and potassium excretion was assessed at 1-, 3-, and 6-hour periods of urine collection. Urine sample was analysed for sodium and potassium concentration using a flame photometer. The role of NAD(P)H oxidase-dependent signalling cascade was evaluated using the selective NAD(P)H oxidase inhibitor, apocynin; the superoxide dismutase mimetic, 4-hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl (tempol); and the protein kinase C inhibitor, chelerythrine.
ICV administration of Ang II to conscious hydrated rats resulted in a significant decrease in urinary volume in the first hour, and an increased sodium and potassium excretion during the 6-hour period of urine collection, which was most effective during the 3 and 6 h. Interference with the NAD(P)H oxidase signalling by central administration of apocynin, tempol or chelerythrine, blunted the natriuretic and kaliuretic effect induced by central administration of Ang II, without affecting its antidiuretic action.
This study demonstrates that increases of urinary sodium and potassium excretion elicited by central administration of Ang II are mediated by NAD(P)H oxidase- dependent production of superoxide and protein kinase C activation in conscious hydrated rats.
已知中枢给予血管紧张素II(Ang II)可减少尿量,并增加钠和钾排泄。最近,已表明Ang II在外周的一种新型信号传导机制涉及烟酰胺腺嘌呤二核苷酸磷酸[NAD(P)H]氧化酶衍生的活性氧(ROS)减少。尽管现在已知ROS参与外周组织中众多Ang II调节的过程,并且越来越多地与中枢神经系统神经退行性疾病有关,但ROS在Ang II诱导的水电解质代谢的中枢调节中的作用仍未得到探索。通过使用NAD(P)H氧化酶级联的选择性拮抗剂,测试了ROS参与中枢Ang II信号传导以及Ang II依赖性抗利尿、利钠和利尿作用的假设。
在脑室内(ICV)插管的大鼠中,经ICV注射Ang II,并在收集尿液的1小时、3小时和6小时期间评估尿钠和钾排泄。使用火焰光度计分析尿液样本中的钠和钾浓度。使用选择性NAD(P)H氧化酶抑制剂阿朴吗啡、超氧化物歧化酶模拟物4-羟基-2,2,6,6-四甲基哌啶-1-氧基(Tempol)和蛋白激酶C抑制剂白屈菜红碱评估NAD(P)H氧化酶依赖性信号传导级联的作用。
向清醒的水合大鼠ICV给予Ang II导致第一小时尿量显著减少,并且在收集尿液的6小时期间钠和钾排泄增加,在3小时和6小时时最为明显。通过中枢给予阿朴吗啡、Tempol或白屈菜红碱干扰NAD(P)H氧化酶信号传导,减弱了中枢给予Ang II诱导的利钠和利尿作用,而不影响其抗利尿作用。
本研究表明,在清醒的水合大鼠中,中枢给予Ang II引起的尿钠和钾排泄增加是由NAD(P)H氧化酶依赖性超氧化物生成和蛋白激酶C激活介导的。